| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 11 |
| 1 | PANCRELIPASE | 11 |
| 2 | LEVOFLOXACIN | 10 |
| 3 | LEVOFLOXACIN IN 5% DEXTROSE | 10 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 9 |
| 5 | RIFAMPIN | 9 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED | 8 |
| 7 | RIFAMPICIN | 6 |
| 8 | CETIRIZINE | 3 |
| 9 | CETIRIZINE HYDROCHLORIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 1 | 0.0028 |
| 1 | RIFAMPIN | 9 | 0.0006 |
| 2 | RIFAMPICIN | 6 | 0.0006 |
| 3 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 4 | PANCRELIPASE | 11 | 0.0003 |
| 5 | FLECAINIDE ACETATE | 1 | 0.0002 |
| 6 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 1 | 0.0002 |
| 7 | LEVOFLOXACIN | 10 | 0.0002 |
| 8 | TIGECYCLINE | 1 | 0.0002 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 11 |
| 1 | Fluoroquinolone Antibacterial [EPC] | 10 |
| 2 | Rifamycin Antibacterial [EPC] | 9 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 8 |
| 4 | Insulin Analog [EPC] | 4 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 6 | Alkylating Drug [EPC] | 2 |
| 7 | Corticosteroid [EPC] | 2 |
| 8 | Insulin [EPC] | 2 |
| 9 | Osmotic Laxative [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antibacterial [EPC] | 9 | 0.0002 |
| 1 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 2 | Anti-IgE [EPC] | 11 | 0.0001 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 8 | 0.0001 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 10 | 0.0001 |
| 5 | Phenothiazine [EPC] | 2 | 0.0001 |
| 6 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Insulin [EPC] | 2 | 0.0000 |